Clinical Pharmacy Specialist, Leukemia
Division of Pharmacy
University of Texas MD Anderson Cancer Center
This program has been made available online.
Expert case-based text module on managing toxicities with BCL-2 and PI3K inhibitors in CLL, from Clinical Care Options (CCO)
Clinical Care Options (CCO): Experts John M. Burke, MD, and Peter Martin, MD, review key data in lymphomas and CLL presented at the 2021 American Society of Hematology Annual Meeting
Downloadable slideset from a local live webinar developed by lymphoma experts with guidance on the management of indolent lymphomas
Download this online resource developed for healthcare professionals with a helpful guide for antibody-based therapies in B-cell lymphoma